Dextromethorphan and Quinidine for Treating Agitation in Patients With Alzheimer Disease Dementia

被引：5
|
作者：
Ballard, Clive [1 ]
Sharp, Samantha [1 ]
Corbett, Anne [1 ]
机构：
[1] Kings Coll London, Wolfson Ctr Age Related Dis, London SE1 1UL, England
来源：
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2015年 / 314卷 / 12期
关键词：
CARE; AGGRESSION; PEOPLE;
D O I：
10.1001/jama.2015.10215
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：1233 / 1235
页数：3
相关论文
共 50 条
  • [21] Dextromethorphan/quinidine (AVP-923) Efficacy and Safety for Treatment of Agitation in Persons with Alzheimer's Disease: Results from a Phase 2 Study (NCT01584440)
    Cummings, Jeffrey
    Lyketsos, Constantine G.
    Tariot, Pierre
    Peskind, Elaine
    Nguyen, Uyen
    Knowles, Nadine
    Shin, Paul
    Siffert, Joao
    AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2015, 23 (03): : S164 - S165
  • [22] Dextromethorphan/Quinidine (AVP-923) Efficacy and Safety for Treatment of Agitation in Persons With Alzheimer's Disease: Results From a Phase 2 Study (NCT01584440)
    Cummins, J.
    Lyketsos, C.
    Tariot, P. N.
    Peskind, E. R.
    Nguyen, U.
    Knowles, N.
    Shin, P.
    Siffert, J.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2015, 63 : S32 - S32
  • [23] Dextromethorphan/Quinidine (AVP-923) Efficacy and Safety for Treatment of Agitation in Alzheimer's Disease (AD): Results from a Phase 2 Study (NCT01584440)
    Cummings, Jeffrey
    Lyketsos, Constantine
    Tariot, Pierre
    Peskind, Elaine
    Uyen Nguyen
    Knowles, Nadine
    Shin, Paul
    Siffert, Joao
    ANNALS OF NEUROLOGY, 2014, 76 : S100 - S101
  • [24] Safety and Tolerability of Dextromethorphan/Quinidine in Older Patients
    D'Amico, Stephen
    Alexander, David N.
    Cutler, Andrew J.
    Zorowitz, Richard D.
    Davis, Charles S.
    Shin, Paul
    Ledon, Frederic
    Formella, Andrea E.
    AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2017, 25 (03): : S142 - S142
  • [25] Treating pain in patients with dementia and the possible concomitant relief of symptoms of agitation
    Pergolizzi, Joseph, V
    Raffa, Robert B.
    Paladini, Antonella
    Varrasi, Giustino
    LeQuang, Jo Ann
    PAIN MANAGEMENT, 2019, 9 (06) : 569 - 582
  • [26] Antipsychotics for agitation and psychosis in people with Alzheimer's disease and vascular dementia
    Muehlbauer, Viktoria
    Moehler, Ralph
    Dichter, Martin N.
    Zuidema, Sytse U.
    Koepke, Sascha
    Luijendijk, Hendrika J.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2021, (12):
  • [27] Assessment of agitation in Alzheimer's disease: The agitated behavior in dementia scale
    Logsdon, RG
    Teri, L
    Weiner, MF
    Gibbons, LE
    Raskind, M
    Peskind, E
    Grundman, M
    Koss, E
    Thomas, RG
    Thal, LJ
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 1999, 47 (11) : 1354 - 1358
  • [28] Investigational drugs for treating agitation in persons with dementia
    Garay, Ricardo P.
    Citrome, Leslie
    Grossberg, George T.
    Cavero, Icilio
    Llorca, Pierre-Michel
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2016, 25 (08) : 973 - 983
  • [29] Assessment of Use of Combined Dextromethorphan and Quinidine in Patients With Dementia or Parkinson Disease After US Food and Drug Administration Approval for Pseudobulbar Affect
    Fralick, Michael
    Sacks, Chana A.
    Kesselheim, Aaron S.
    JAMA INTERNAL MEDICINE, 2019, 179 (02) : 224 - 230
  • [30] Guidelines for treating dementia-associated agitation
    Goldsmith, MF
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 279 (22): : 1770 - 1770
12345